» Articles » PMID: 22777949

In Search of an Osteoblast Cell Model for in Vitro Research

Overview
Journal Eur Cell Mater
Date 2012 Jul 11
PMID 22777949
Citations 184
Authors
Affiliations
Soon will be listed here.
Abstract

The process of bone formation, remodelling and healing involves a coordinated action of various cell types. Advances in understanding the biology of osteoblast cells during these processes have been enabled through the use of various in vitro culture models from different origins. In an era of intensive bone tissue engineering research, these cell models are more and more often applied due to limited availability of primary human osteoblast cells. While they are a helpful tool in developing novel therapies or biomaterials; concerns arise regarding their phenotypic state and differences in relation to primary human osteoblast cells. In this review we discuss the osteoblastic development of some of the available cell models; such as primary human, rat, mouse, bovine, ovine and rabbit osteoblast cells; as well as MC3T3-E1, MG-63 and SaOs-2 cell lines, together with their advantages and disadvantages. Through this, we provide suggestions on the selection of the appropriate and most relevant osteoblast model for in vitro studies, with specific emphasis on cell-material based studies.

Citing Articles

Trabecular-bone mimicking osteoconductive collagen scaffolds: an optimized 3D printing approach using freeform reversible embedding of suspended hydrogels.

Kontakis M, Moulin M, Andersson B, Norein N, Samanta A, Stelzl C 3D Print Med. 2025; 11(1):11.

PMID: 40064747 PMC: 11895158. DOI: 10.1186/s41205-025-00255-0.


Implant-Derived Isolates Drive Strain-Specific Invasion Dynamics and Bioenergetic Alterations in Osteoblasts.

Song L, Schwinn L, Barthel J, Ketter V, Lechler P, Linne U Antibiotics (Basel). 2025; 14(2).

PMID: 40001363 PMC: 11852183. DOI: 10.3390/antibiotics14020119.


Ionic silver coating of orthopedic implants may impair osteogenic differentiation and mineralization.

Kontakis M, Carlsson E, Palo-Nieto C, Hailer N Exp Ther Med. 2025; 29(3):51.

PMID: 39885915 PMC: 11775765. DOI: 10.3892/etm.2025.12801.


and Evaluation of the Cytotoxic Potential of Hinokitiol against Osteosarcoma by Targeting Glycogen Synthase Kinase 3β.

Cheriyan B, Srinivasan P, Jayaraj G, Karunakar K, Sainath P, Shanmugam A Turk J Pharm Sci. 2025; 21(6):499-505.

PMID: 39801001 PMC: 11730009. DOI: 10.4274/tjps.galenos.2023.65708.


Hypoxia Compromises the Differentiation of Human Osteosarcoma Cells to CAR-R, a Hydroxylated Derivative of Lithocholic Acid and Potent Agonist of the Vitamin D Receptor.

Evans H, Greenhough A, Perry L, Lasanta G, Gonzalez C, Mourino A Int J Mol Sci. 2025; 26(1.

PMID: 39796220 PMC: 11720546. DOI: 10.3390/ijms26010365.